Ventana Medical Systems News

Varicent Software Incorporated starts 2012 on the heels of a successful and productive year of growth.

On Tuesday January 24th, European pharmaceutical giant Roche announced it will seek to acquire all outstanding shares of Illumina Inc , a U.S. developer of DNA sequencing tools for $44.50 a share in cash.

Roche Holding AG offered about $5.7 billion in cash for Illumina Inc. to bolster cancer-drug sales, the third time since 2007 the Swiss drugmaker has made a hostile bid for a U.S. company.

Stratifying patients for the appropriate, targeted therapy may prove to be a significant step towards personalized medicine in cancer treatment /PRNewswire/ -- Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. to Collaborate with Pfizer Inc. and Cell Signaling Technology, Inc.